Developer docs
API playgroundTry for free, no card

Search company profiles

mzio

Full company profile

uuid0004bz4

Namestring
mzio
Legal namestring
mzio GmbH
Websiteurl
mzio.io
Company typeenum
Private
Founded yearint
2020
Descriptiontext

mzio GmbH is a German private limited company headquartered in Bremen that develops and commercializes mzmine, an open-source mass spectrometry data analysis platform with 20 years of underlying R&D heritage. The platform supports multimodal data analysis across LC-MS, GC-MS, ion mobility spectrometry-MS, and MS imaging workflows, with proprietary modules including mzwizard for automated workflow generation, Interactive Molecular Networking (IIN/FBMN) embedding DreaMS and MS2Deepscore deep learning models, and a Statistics and Fragmentation Dashboard with MS2-based formula prediction. The architecture is modular and open-source, enabling independent module development by global contributors and supporting broad vendor format compatibility (Waters MassLynx, Thermo, Bruker, SCIEX, mzML).

mzio operates a hybrid go-to-market combining community-led open-source adoption with enterprise SaaS. Distribution is structured as four tiers: Community (free for academic users at degree-awarding institutions), CORE (commercial use for teams up to 3 users), PLUS (labs up to 5 users with email support and IT integration), and PRO (enterprise-grade with MRM and UV/ELSD detector support). The academic Community edition has accumulated 10,000+ active users and 6,000+ peer-reviewed citations, providing top-of-funnel demand for commercial conversion. Strategic partnerships with SCIEX (embedded in SCIEX OS 5.0 for ZenoTOF), Bright Giant (one-click SIRIUS integration), and the Functional Genomics Center Zurich (metabolomics/lipidomics co-development) extend distribution and ecosystem reach.

The company is led by Managing Director Dr. Ansgar Korf alongside four co-founders spanning CEO (Korf), CTO (Steffen Heuckeroth), CFO (Ludger Rothues), and scientific advisory (Tomáš Pluskal) functions. Revenue is generated primarily through tiered commercial software licensing with a minimum one-year commitment, supplemented by non-dilutive EU/ZIM and German state grants totaling approximately €517,758 across two tranches (August 2024 and May 2026). No private equity or venture capital investment is disclosed, and revenue figures are not publicly available. The customer base spans academic research institutions, analytical and scientific labs, biopharma/pharma/biotech/CRO segments, and specialized use cases including lipidomics, MS imaging, polymer/PFAS analysis, and drug discovery.

Short descriptiontext

mzio GmbH commercializes mzmine, an open-source mass spectrometry data analysis platform used by 10,000+ researchers globally for metabolomics, lipidomics, and MS imaging across academic labs and commercial enterprises via tiered licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBremen, Germany
HQ citystring
Bremen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mass spectrometry software, metabolomics data analysis, LC-MS processing, scientific research software, lipidomics analytics
Industry2 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Mass Spectrometry Data Analysis Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licensing (Commercial)
TypeSubscription Recurring
Description

Tiered commercial licensing model for mzmine software: CORE (commercial use, small teams up to 3 users), PLUS (email support, IT integration, onboarding, labs up to 5 users), and PRO (enterprise-grade with MRM support, UV/ELSD detectors, maximized lab performance). All plans include unlimited updates and software access per selected plan with minimum 1-year commitment.

mzio.io
2Academic/Community Licensing
TypeFreemium
Description

Free-of-charge access for students, teachers, and researchers at degree-awarding academic institutions through the Academic Program. Provides full Community edition for educational and non-commercial research purposes.

mzio.io
3Research Grants & Government Funding
TypeLicensing Royalties
Description

Non-dilutive funding from EU and German government programs supporting R&D for AI-powered FAIR-MS initiative and LIMMIC project for multidimensional MS calibration.

mzio.io
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Pricing details4 tiers
1Community - Free for academics
ModelFreemiumBilling cadenceAnnual
Notes

Free-of-charge for educational institutions (students, lecturers, staff at degree-awarding institutions). Includes GitHub Forum support and unlimited updates.

mzio.io
2CORE - Commercial use for small teams
ModelSubscriptionBilling cadenceAnnual
Notes

Software access with commercial use rights for small teams up to 3 users. Includes unlimited updates.

mzio.io
3PLUS - Enhanced support and integration
ModelSubscriptionBilling cadenceAnnual
Notes

Email support (max 5 working days response), IT integration assistance, onboarding session, for labs up to 5 users.

mzio.io
4PRO - Enterprise performance
ModelSubscriptionBilling cadenceAnnual
Notes

Maximized lab performance including MRM support, UV/ELSD and other detector support for enterprise deployments.

mzio.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1mzmine
Description

Open-source mass spectrometry data analysis platform supporting LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging workflows.

mzio.io
+7 more records
Core offering1 text field

mzio develops and commercializes mzmine, an open-source mass spectrometry data analysis platform that processes LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging data for analytical laboratories. The platform is offered through tiered licensing — Community (free for academic users), CORE (commercial use for small teams), PLUS (labs with IT integration and support), and PRO (enterprise-grade for large organizations) — and includes proprietary workflow automation, AI-powered molecular networking, and deep learning spectral comparison.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Process 1000s of samples within minutes
+3 more records
Product overview1 text field

mzio provides mzmine, a scalable mass spectrometry data analysis platform built on 20 years of MS data processing experience with over 6000 citations and 10,000 active users. The product portfolio consists of mzmine as the core platform offering multimodal data analysis for LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging. Distribution tiers include Community (free academic), CORE (commercial small teams), PLUS (labs with IT integration needs), and PRO (enterprise). Supporting tools include mzwizard for workflow automation, Interactive Molecular Networking with DreaMS and MS2Deepscore deep learning models for AI-powered compound discovery, and Statistics/Fragmentation Dashboard for predictive analytics. Documentation includes whitepapers and brochures for enterprise adoption.

Product and service6 records
1mzmine mass spectrometry data analysis platform
CategoryMass spectrometry data analysis software
Description

Scalable mass spectrometry data analysis platform supporting multimodal data analysis for LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging workflows. Built on an open-source modular architecture with established best-practice algorithms for transforming complex MS data into molecular structures.

2mzmine Community
CategoryMass spectrometry data analysis software — academic tier
Description

Free tier of mzmine providing software access, unlimited updates, and GitHub Forum support for students, teachers, and researchers at degree-awarding academic institutions.

3mzmine CORE
CategoryMass spectrometry data analysis software — commercial tier
Description

Commercial-use subscription tier of mzmine providing software access for small teams up to 3 users, with a minimum 1-year commitment and unlimited updates.

4mzmine PLUS
CategoryMass spectrometry data analysis software — commercial tier with support
Description

Subscription tier of mzmine for labs up to 5 users, including email support (max 5 working days response time), IT integration assistance, and an onboarding session.

5mzmine PRO
CategoryMass spectrometry data analysis software — enterprise tier
Description

Enterprise-grade subscription tier of mzmine maximizing lab performance with MRM support, UV/ELSD and other detector support, and full feature access for large organizations.

6mzwizard
CategoryMass spectrometry workflow automation software
Description

User-friendly workflow wizard for mzmine that auto-generates analysis workflows based on the experimental setup, making complex bioinformatics tools easily accessible for LC-MS/MS (DDA and DIA), GC/EI-MS, MS Imaging, and ion mobility spectrometry setups.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-01
Description

SCIEX, a Danaher company and leader in life science analytical technologies, announced mzmine integration as part of SCIEX OS 5.0 software platform for ZenoTOF mass spectrometry line. The integration creates a connected end-to-end solution for proteomics and metabolomics researchers, announced at ASMS 2026 conference.

2Bright Giant GmbH
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-11
Description

Seamless integration between mzmine and SIRIUS software enabling researchers to launch SIRIUS analysis directly from mzmine feature tables with automated result handling. The integration streamlines small molecule discovery workflows and is available with mzmine version 4.8.

mass-spec-capital.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-16
Description

Strategic collaboration to advance development of metabolomics and lipidomics tools. mzio partners with FGCZ to bring mzmine PRO into untargeted metabolomics and lipidomics workflows, combining FGCZ's expertise with mzio's software capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1MetaboAnalyst
TypeEmerging player
Description

Web-based metabolomics data analysis platform from the Xia Lab (McGill) — competing entry point for the same academic researcher audience, particularly for statistical analysis and pathway interpretation downstream of MS feature detection.

TypeBroad incumbent
Description

Agilent's proprietary mass spectrometry software suite for qualitative, quantitative, and bioconfirmance workflows — a major incumbent whose bundled offerings compete with mzmine's multi-vendor positioning.

3Skyline Software
TypeDirect peer
Description

Open-source targeted quantitative MS software from the MacCoss Lab (University of Washington) — overlapping audience of metabolomics and proteomics researchers with shared vendor-format support.

TypeRegional player
Description

European lipidomics services and software company — comparable regional footprint to mzio and overlapping focus on lipidomics workflows, though primarily a fee-for-service CRO model rather than software vendor.

5Bright Giant (SIRIUS)
TypeEmerging player
Description

Developer of SIRIUS for small molecule identification from MS/MS spectra — an existing integration partner of mzmine but also a stand-alone competitor in the molecular networking and compound ID space.

6MaxQuant
TypeDirect peer
Description

Widely-used quantitative proteomics software from the Max Planck Institute of Biochemistry, serving the same academic and industry proteomics researcher audience with a similarly large citation base and free academic distribution.

7MS-DIAL
TypeDirect peer
Description

Open-source mass spectrometry data analysis platform developed at RIKEN for untargeted metabolomics, lipidomics, and MS imaging — directly competes with mzmine in the same workflows and on free academic distribution.

8OpenMS
TypeDirect peer
Description

Open-source C++/Python framework for LC-MS data management and analysis maintained by HHU Düsseldorf, offering an alternative to mzmine for proteomics and metabolomics workflows in academic and industry settings.

9Compound Discoverer (Thermo Fisher Scientific)
TypeBroad incumbent
Description

Thermo Fisher's commercial LC-MS data analysis software bundled with Orbitrap and Tribrid instruments — competes head-on with mzmine PRO in commercial metabolomics, lipidomics, and proteomics workflows within Thermo-installed labs.

TypeBroad incumbent
Description

Bruker's portfolio of MS data analysis tools (including MetaboScape for metabolomics) — direct commercial competition within Bruker timsTOF and MALDI-installed bases that mzmine also targets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

mzio

Mass Spectrometry Data Analysis Softwaremzio.io

mzio GmbH commercializes mzmine, an open-source mass spectrometry data analysis platform used by 10,000+ researchers globally for metabolomics, lipidomics, and MS imaging across academic labs and commercial enterprises via tiered licensing.

What mzio does

mzio GmbH is a German private limited company headquartered in Bremen that develops and commercializes mzmine, an open-source mass spectrometry data analysis platform with 20 years of underlying R&D heritage. The platform supports multimodal data analysis across LC-MS, GC-MS, ion mobility spectrometry-MS, and MS imaging workflows, with proprietary modules including mzwizard for automated workflow generation, Interactive Molecular Networking (IIN/FBMN) embedding DreaMS and MS2Deepscore deep learning models, and a Statistics and Fragmentation Dashboard with MS2-based formula prediction. The architecture is modular and open-source, enabling independent module development by global contributors and supporting broad vendor format compatibility (Waters MassLynx, Thermo, Bruker, SCIEX, mzML).

mzio operates a hybrid go-to-market combining community-led open-source adoption with enterprise SaaS. Distribution is structured as four tiers: Community (free for academic users at degree-awarding institutions), CORE (commercial use for teams up to 3 users), PLUS (labs up to 5 users with email support and IT integration), and PRO (enterprise-grade with MRM and UV/ELSD detector support). The academic Community edition has accumulated 10,000+ active users and 6,000+ peer-reviewed citations, providing top-of-funnel demand for commercial conversion. Strategic partnerships with SCIEX (embedded in SCIEX OS 5.0 for ZenoTOF), Bright Giant (one-click SIRIUS integration), and the Functional Genomics Center Zurich (metabolomics/lipidomics co-development) extend distribution and ecosystem reach.

The company is led by Managing Director Dr. Ansgar Korf alongside four co-founders spanning CEO (Korf), CTO (Steffen Heuckeroth), CFO (Ludger Rothues), and scientific advisory (Tomáš Pluskal) functions. Revenue is generated primarily through tiered commercial software licensing with a minimum one-year commitment, supplemented by non-dilutive EU/ZIM and German state grants totaling approximately €517,758 across two tranches (August 2024 and May 2026). No private equity or venture capital investment is disclosed, and revenue figures are not publicly available. The customer base spans academic research institutions, analytical and scientific labs, biopharma/pharma/biotech/CRO segments, and specialized use cases including lipidomics, MS imaging, polymer/PFAS analysis, and drug discovery.

mzio firmographics

Firmographics
Name
mzio
Legal name
mzio GmbH
Website
https://mzio.io
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
mzio GmbH commercializes mzmine, an open-source mass spectrometry data analysis platform used by 10,000+ researchers globally for metabolomics, lipidomics, and MS imaging across academic labs and commercial enterprises via tiered licensing.
Ownership category
akta.pro rank

mzio industry classification

Industry
Product category
Mass Spectrometry Data Analysis Software
NAICS
Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Mass spectrometry software
  • Metabolomics data analysis
  • LC-MS processing
  • Scientific research software
  • Lipidomics analytics

Where mzio is headquartered

Location

Headquarters

HQ city
Bremen
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

mzio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. Software Licensing (Commercial): Tiered commercial licensing model for mzmine software: CORE (commercial use, small teams up to 3 users), PLUS (email support, IT integration, onboarding, labs up to 5 users), and PRO (enterprise-grade with MRM support, UV/ELSD detectors, maximized lab performance). All plans include unlimited updates and software access per selected plan with minimum 1-year commitment.
  2. Academic/Community Licensing: Free-of-charge access for students, teachers, and researchers at degree-awarding academic institutions through the Academic Program. Provides full Community edition for educational and non-commercial research purposes.
  3. Research Grants & Government Funding: Non-dilutive funding from EU and German government programs supporting R&D for AI-powered FAIR-MS initiative and LIMMIC project for multidimensional MS calibration.

Pricing tiers

ModelBillingPrice
FreemiumAnnualCommunity - Free for academics
SubscriptionAnnualCORE - Commercial use for small teams
SubscriptionAnnualPLUS - Enhanced support and integration
SubscriptionAnnualPRO - Enterprise performance

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

mzio product offering

Product offering

Core offering

mzio develops and commercializes mzmine, an open-source mass spectrometry data analysis platform that processes LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging data for analytical laboratories. The platform is offered through tiered licensing — Community (free for academic users), CORE (commercial use for small teams), PLUS (labs with IT integration and support), and PRO (enterprise-grade for large organizations) — and includes proprietary workflow automation, AI-powered molecular networking, and deep learning spectral comparison.

Product overview

mzio provides mzmine, a scalable mass spectrometry data analysis platform built on 20 years of MS data processing experience with over 6000 citations and 10,000 active users. The product portfolio consists of mzmine as the core platform offering multimodal data analysis for LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging. Distribution tiers include Community (free academic), CORE (commercial small teams), PLUS (labs with IT integration needs), and PRO (enterprise). Supporting tools include mzwizard for workflow automation, Interactive Molecular Networking with DreaMS and MS2Deepscore deep learning models for AI-powered compound discovery, and Statistics/Fragmentation Dashboard for predictive analytics. Documentation includes whitepapers and brochures for enterprise adoption.

Differentiator

Problem solved

Functional benefit

Brands

  • mzmine: Open-source mass spectrometry data analysis platform supporting LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging workflows.
  • mzmine Community
  • mzmine CORE
  • mzmine PLUS
  • mzmine PRO
  • mzwizard
  • Interactive Molecular Networking
  • DreaMS

Products and services

  • mzmine mass spectrometry data analysis platform Scalable mass spectrometry data analysis platform supporting multimodal data analysis for LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging workflows. Built on an open-source modular architecture with established best-practice algorithms for transforming complex MS data into molecular structures.
  • mzmine Community Free tier of mzmine providing software access, unlimited updates, and GitHub Forum support for students, teachers, and researchers at degree-awarding academic institutions.
  • mzmine CORE Commercial-use subscription tier of mzmine providing software access for small teams up to 3 users, with a minimum 1-year commitment and unlimited updates.
  • mzmine PLUS Subscription tier of mzmine for labs up to 5 users, including email support (max 5 working days response time), IT integration assistance, and an onboarding session.
  • mzmine PRO Enterprise-grade subscription tier of mzmine maximizing lab performance with MRM support, UV/ELSD and other detector support, and full feature access for large organizations.
  • mzwizard User-friendly workflow wizard for mzmine that auto-generates analysis workflows based on the experimental setup, making complex bioinformatics tools easily accessible for LC-MS/MS (DDA and DIA), GC/EI-MS, MS Imaging, and ion mobility spectrometry setups.

Quantifiable outcome

  • Process 1000s of samples within minutes
  • +3 more outcomes

Companies that use mzio

Customer profile

Segments7 records

Ideal customer profiles3 records

mzio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature11 records

mzio partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SCIEX (Danaher)coreTechnology or Integration · 1 June 2026SCIEX, a Danaher company and leader in life science analytical technologies, announced mzmine integration as part of SCIEX OS 5.0 software platform for ZenoTOF mass spectrometry line. The integration creates a connected end-to-end solution for proteomics and metabolomics researchers, announced at ASMS 2026 conference.
  • Bright Giant GmbHcoreTechnology or Integration · 11 November 2025Seamless integration between mzmine and SIRIUS software enabling researchers to launch SIRIUS analysis directly from mzmine feature tables with automated result handling. The integration streamlines small molecule discovery workflows and is available with mzmine version 4.8.
  • Functional Genomics Center Zurich (FGCZ, ETH Zurich / University of Zurich)coreStrategic or Co-development Partner · 16 April 2025Strategic collaboration to advance development of metabolomics and lipidomics tools. mzio partners with FGCZ to bring mzmine PRO into untargeted metabolomics and lipidomics workflows, combining FGCZ's expertise with mzio's software capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

mzio competitors and assessment

Company assessment

Emerging players

  • MetaboAnalyst: Web-based metabolomics data analysis platform from the Xia Lab (McGill) — competing entry point for the same academic researcher audience, particularly for statistical analysis and pathway interpretation downstream of MS feature detection.
  • Bright Giant (SIRIUS): Developer of SIRIUS for small molecule identification from MS/MS spectra — an existing integration partner of mzmine but also a stand-alone competitor in the molecular networking and compound ID space.

Broad incumbents

  • Agilent MassHunter: Agilent's proprietary mass spectrometry software suite for qualitative, quantitative, and bioconfirmance workflows — a major incumbent whose bundled offerings compete with mzmine's multi-vendor positioning.
  • Compound Discoverer (Thermo Fisher Scientific): Thermo Fisher's commercial LC-MS data analysis software bundled with Orbitrap and Tribrid instruments — competes head-on with mzmine PRO in commercial metabolomics, lipidomics, and proteomics workflows within Thermo-installed labs.
  • Bruker Compass / MetaboScape: Bruker's portfolio of MS data analysis tools (including MetaboScape for metabolomics) — direct commercial competition within Bruker timsTOF and MALDI-installed bases that mzmine also targets.

Direct peers

  • Skyline Software: Open-source targeted quantitative MS software from the MacCoss Lab (University of Washington) — overlapping audience of metabolomics and proteomics researchers with shared vendor-format support.
  • MaxQuant: Widely-used quantitative proteomics software from the Max Planck Institute of Biochemistry, serving the same academic and industry proteomics researcher audience with a similarly large citation base and free academic distribution.
  • MS-DIAL: Open-source mass spectrometry data analysis platform developed at RIKEN for untargeted metabolomics, lipidomics, and MS imaging — directly competes with mzmine in the same workflows and on free academic distribution.
  • OpenMS: Open-source C++/Python framework for LC-MS data management and analysis maintained by HHU Düsseldorf, offering an alternative to mzmine for proteomics and metabolomics workflows in academic and industry settings.

Regional players

  • Lipotype (Dortmund/now part of Evotec): European lipidomics services and software company — comparable regional footprint to mzio and overlapping focus on lipidomics workflows, though primarily a fee-for-service CRO model rather than software vendor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

mzio social profiles

Digital presence

mzio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

mzio leadership team

Management profile

Number of profiles

Profiles5 records

mzio funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

mzio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about mzio

What does mzio do?

mzio develops and commercializes mzmine, an open-source mass spectrometry data analysis platform that processes LC-MS, GC-MS, ion mobility spectrometry-MS, and MS Imaging data for analytical laboratories. The platform is offered through tiered licensing — Community (free for academic users), CORE (commercial use for small teams), PLUS (labs with IT integration and support), and PRO (enterprise-grade for large organizations) — and includes proprietary workflow automation, AI-powered molecular networking, and deep learning spectral comparison.

Is mzio a public or private company?

mzio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was mzio founded?

mzio was founded in 2020. It employs 1 to 10 people.

Where is mzio based?

mzio is headquartered in Bremen, Germany, in the Europe region.

How does mzio make money?

Three revenue lines are on record. Software Licensing (Commercial) is the primary driver. The others are academic/Community Licensing and research Grants & Government Funding.

Who are mzio's main competitors?

Emerging players on record are MetaboAnalyst and Bright Giant (SIRIUS). Broad incumbents are Agilent MassHunter, Compound Discoverer (Thermo Fisher Scientific) and Bruker Compass / MetaboScape. Direct peers are Skyline Software, MaxQuant, MS-DIAL and OpenMS. Lipotype (Dortmund/now part of Evotec) is listed as a regional player.

Does mzio have an API?

No public API is recorded for mzio.

What industry is mzio in?

mzio's product category is Mass Spectrometry Data Analysis Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 5417 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesThe SCIEX ZenoTOF series has evolved through platform expansion via software, integrated processing, and collaboration.SCIEX announced an evolution of its ZenoTOF series platform, including new software features and integrations. The update adds ZT Scan DIA 3.0, enhanced sensitivity modes, and integrations with PEAKS and MS-DIAL. The company aims to reduce workflow complexity and expand application areas.Business Wire BlogSCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key CollaborationsAt ASMS, SCIEX introduced platform-wide advancements for its ZenoTOF line, including SCIEX OS 5.0 software and new integrations. The updates include ZT Scan DIA 3.0 and collaborations with BSI and MS-Dial, with ZenoTOF 8600 showing 10-40% gains in low-input proteomics.The Mass Spectrometry Web Portalmzio GmbH. (8/21/24). "Press Release: mzio GmbH Secures €150,000 Funding to Develop mzmine PRO as Part of the “BRE-Up Start-up Funding Bremen”".mzio GmbH received €150,000 in funding under the BRE-Up Start-up Funding Bremen program to develop mzmine PRO, a mass spectrometry data processing software. The funding will enable integration of sampling technologies like LC, GC, and MALDI, and mzmine will remain open-source.The Mass Spectrometry Web PortalBright Giant GmbH. (11/11/25). "Press Release: mzio GmbH and Bright Giant GmbH Announce Seamless Integration Between mzmine and SIRIUS". Bremen & Jena.mzio GmbH and Bright Giant GmbH announced a new integration between their mass spectrometry software platforms mzmine and SIRIUS, enabling researchers to launch SIRIUS analysis directly from mzmine feature tables with automated result handling. The collaboration eliminates manual data transfer between platforms, streamlining small molecule discovery workflows for researchers worldwide. The integration will be available with the upcoming release of mzmine version 4.8.The Mass Spectrometry Web Portalmzio–Bright Giant: mass spectrometry software, 202511 collab product integration of mzmine s/w + SIRIUS s/wmzio GmbH and Bright Giant GmbH announced a new software integration between their mass spectrometry platforms, mzmine and SIRIUS, enabling researchers to launch SIRIUS analysis directly from within mzmine and automatically receive results without manual data transfer. The integration is designed to streamline small molecule discovery workflows and will be available with the upcoming release of mzmine version 4.8, compatible with the latest SIRIUS version. This partnership marks an effort toward unified small molecule data analysis, connecting two leading mass spectrometry software solutions for the global research community.